Biocon — Biosimilars Portfolio
Provider 
Founded 1978
Sells To Enterprise, Government
Pricing Model Recurring, Software, Transactional
Ownership Public

Biocon's biosimilars portfolio spans trastuzumab, bevacizumab, pegfilgrastim, adalimumab, etanercept, and aflibercept products.
Biocon develops and manufactures biosimilars overlapping the focal cohort's therapeutic areas, including trastuzumab, bevacizumab, pegfilgrastim, adalimumab, etanercept, and aflibercept.
Biocon partners with Bahiafarma under Brazil's Parcerias para o Desenvolvimento Produtivo (PDP) program to supply biosimilars in the Brazilian market.
Bionovis

Bionovis — Biologic and Biosimilar Medicines
bionovis.com.br
Sandoz

Biosimilars
sandoz.com
Cristália

Biotechnology APIs & Biosimilars
cristalia.com.br
| Attribute | Biocon — Biosimilars Portfolio | Bionovis — Biologic and Biosimilar Medicines | Biosimilars | Biotechnology APIs & Biosimilars | |
|---|---|---|---|---|---|
| Provider | |||||
| Founded | 1978 | 2012 | 1886 | 1972 | |
| Sells To | Enterprise, Government | — | Healthcare Providers, Hospitals, Retail | Consumers, Hospitals | |
| Pricing Model | Recurring, Software, Transactional | — | B2B, Product Sales | Product Sales | |
| Ownership | Public | — | Public | Private |
Provider 
Founded 1978
Sells To Enterprise, Government
Pricing Model Recurring, Software, Transactional
Ownership Public
Provider 
Founded 2012
Sells To —
Pricing Model —
Ownership —
Provider 
Founded 1886
Sells To Healthcare Providers, Hospitals, Retail
Pricing Model B2B, Product Sales
Ownership Public
Provider 
Founded 1972
Sells To Consumers, Hospitals
Pricing Model Product Sales
Ownership Private
Samsung Bioepis's biosimilars portfolio includes etanercept, adalimumab, infliximab, trastuzumab, and aflibercept products.


Biopharma business unit of Fresenius Kabi Brasil offering biosimilar medicines in Brazil.

Samsung Bioepis's biosimilars portfolio includes etanercept, adalimumab, infliximab, trastuzumab, and aflibercept products.
Biopharma business unit of Fresenius Kabi Brasil offering biosimilar medicines in Brazil.

Truxima is a rituximab biosimilar medicine used in blood cancer and autoimmune care.
